Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Shanghai Stock Exchange  >  WuXi AppTec Co., Ltd.    603259   CNE1000031K4

WUXI APPTEC CO., LTD.

(603259)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
08/03/2020 08/04/2020 08/05/2020 08/06/2020 08/07/2020 Date
112.93 114.26 117 114.4 111.9 Last
13499080 14605430 14666680 14981410 17896420 Volume
-0.06% +1.18% +2.40% -2.22% -2.19% Change
Financials
Sales 2020 16 334 M 2 344 M 2 344 M
Net income 2020 2 636 M 378 M 378 M
Net cash position 2020 3 596 M 516 M 516 M
P/E ratio 2020 95,4x
Yield 2020 0,33%
Sales 2021 20 630 M 2 961 M 2 961 M
Net income 2021 3 469 M 498 M 498 M
Net cash position 2021 5 776 M 829 M 829 M
P/E ratio 2021 71,4x
Yield 2021 0,38%
Capitalization 265 B 38 070 M 38 074 M
EV / Sales 2020 16,0x
EV / Sales 2021 12,6x
Nbr of Employees 22 233
Free-Float 48,3%
More Financials
Company
WuXi AppTec Co., Ltd. specializes in providing a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical and biotech industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. Net sales break down by activity as follows: - laboratory services (65,7%): small molecules discovery services, bioanalytical services, medical devices safety... 
More about the company
Surperformance© ratings of WuXi AppTec Co., Ltd.
Trading Rating : Investor Rating :
More Ratings
Latest news on WUXI APPTEC CO., LTD.
08/05WUXI APPTEC : Completion of placing of new h shares under specific mandate
PU
07/28WUXI APPTEC : Placing of new h shares under specific mandate
PU
07/28WuXi AppTec Plans to Raise US$940 Million via Share Placement
DJ
07/20WUXI APPTEC : Net Profit Soared in Second Quarter
DJ
06/07Warburg Pincus-Backed Hygeia Healthcare Plans Hong Kong IPO
DJ
03/26Asia bankers look to follow-on deals as capital raising hits 12-year low
RE
03/24WUXI APPTEC : Plans Private Share Placement
DJ
03/20WUXI APPTEC CO., LTD. : annual earnings release
01/03WUXI APPTEC : STA Pharmaceutical - WuXi STA Opens Oligonucleotide Large-Scale Ma..
AQ
2019WUXI APPTEC : ATU and GeneMedicine Sign Development and Manufacturing Agreement ..
AQ
2019China's major shareholders sell A-shares, pressuring markets
RE
2019WUXI APPTEC : 1) adjustments to the number of the incentive participants and num..
PU
2019WUXI APPTEC : Inside information - proposed disposal of a shares by shareholders
PU
2019WUXI APPTEC : Lab Testing Division Expands Toxicology Facility in Suzhou, China
AQ
2019WUXI APPTEC : Dr. Ge Li Awarded 'CEO of the Year' at CPhI Worldwide 2019
AQ
More news
News in other languages on WUXI APPTEC CO., LTD.
08/05WUXI APPTEC : Completion of placing of new h shares under specific mandate
07/28WUXI APPTEC : Placing of new h shares under specific mandate
07/28WuXi AppTec Plans to Raise US$940 Million via Share Placement
07/20WUXI APPTEC : Net Profit Soared in Second Quarter
06/07Warburg Pincus-Backed Hygeia Healthcare Plans Hong Kong IPO
More news
Chart WUXI APPTEC CO., LTD.
Duration : Period :
WuXi AppTec Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WUXI APPTEC CO., LTD.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 19
Average target price 101,29 CNY
Last Close Price 111,90 CNY
Spread / Highest target 33,6%
Spread / Average Target -9,48%
Spread / Lowest Target -39,4%
EPS Revisions
Managers
NameTitle
Ge Li Chairman, President & Co-Chief Executive Officer
Qing Yang Co-CEO, Executive Director & Executive VP
Harry He Chairman-Supervisory Board
Guo Dong Tong Chief Operating Officer & Senior Vice President
Ellis Chu Chief Financial Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
WUXI APPTEC CO., LTD.70.06%38 070
GILEAD SCIENCES, INC.6.73%86 946
VERTEX PHARMACEUTICALS24.68%71 105
REGENERON PHARMACEUTICALS65.18%65 265
GENMAB A/S55.18%23 785
BEIGENE, LTD.33.02%19 953